Cell‐Free Extracts from Human Fat Tissue with a Hyaluronan‐Based Hydrogel Attenuate Inflammation in a Spinal Cord Injury Model through M2 Microglia/Microphage Polarization

Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Small (Weinheim an der Bergstrasse, Germany) Ročník 18; číslo 17; s. e2107838 - n/a
Hlavní autoři: Xu, Guang‐Yu, Xu, Shun, Zhang, Yu‐Xuan, Yu, Zi‐You, Zou, Fei, Ma, Xiao‐Sheng, Xia, Xin‐Lei, Zhang, Wen‐Jie, Jiang, Jian‐Yuan, Song, Jian
Médium: Journal Article
Jazyk:angličtina
Vydáno: Germany Wiley Subscription Services, Inc 01.04.2022
Témata:
ISSN:1613-6810, 1613-6829, 1613-6829
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro‐ and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti‐inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg‐1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective. Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice, which demonstrate an impressing recovery.
AbstractList Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro‐ and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti‐inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg‐1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective.
Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell-free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro- and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti-inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg-1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective.Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell-free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro- and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti-inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg-1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective.
Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro‐ and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti‐inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg‐1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective. Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice, which demonstrate an impressing recovery.
Author Xu, Shun
Zhang, Wen‐Jie
Ma, Xiao‐Sheng
Zhang, Yu‐Xuan
Yu, Zi‐You
Zou, Fei
Xia, Xin‐Lei
Jiang, Jian‐Yuan
Xu, Guang‐Yu
Song, Jian
Author_xml – sequence: 1
  givenname: Guang‐Yu
  surname: Xu
  fullname: Xu, Guang‐Yu
  organization: Fudan University
– sequence: 2
  givenname: Shun
  surname: Xu
  fullname: Xu, Shun
  organization: Fudan University
– sequence: 3
  givenname: Yu‐Xuan
  surname: Zhang
  fullname: Zhang, Yu‐Xuan
  organization: Fudan University
– sequence: 4
  givenname: Zi‐You
  surname: Yu
  fullname: Yu, Zi‐You
  organization: Shanghai Key Laboratory of Tissue Engineering
– sequence: 5
  givenname: Fei
  surname: Zou
  fullname: Zou, Fei
  organization: Fudan University
– sequence: 6
  givenname: Xiao‐Sheng
  surname: Ma
  fullname: Ma, Xiao‐Sheng
  organization: Fudan University
– sequence: 7
  givenname: Xin‐Lei
  surname: Xia
  fullname: Xia, Xin‐Lei
  organization: Fudan University
– sequence: 8
  givenname: Wen‐Jie
  surname: Zhang
  fullname: Zhang, Wen‐Jie
  organization: Shanghai Key Laboratory of Tissue Engineering
– sequence: 9
  givenname: Jian‐Yuan
  surname: Jiang
  fullname: Jiang, Jian‐Yuan
  email: jianyuanjiang@sina.com
  organization: Fudan University
– sequence: 10
  givenname: Jian
  orcidid: 0000-0001-5850-025X
  surname: Song
  fullname: Song, Jian
  email: jsong16@fudan.edu.cn
  organization: Fudan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35333441$$D View this record in MEDLINE/PubMed
BookMark eNqFkctuEzEUhkeoiF5gyxJZYsMmqW9zW5aoaSolAqllPToz9iSOPHbwRSWseIS-Ce_Ek-AkJUiVECsf2d93rHP-8-zEWCOz7C3BY4IxvfSD1mOKKcFlxaoX2RkpCBsVFa1PjjXBp9m592uMGaG8fJWdspwxxjk5y35OpNa_fjxOnZTo-ltw0AWPemcHNIsDGDSFgO6V91GiBxVWCNBsCzo6a8Ak7yN4KdKVcHYpNboKQZoIQaJb02sYBgjKGqRM8u42yoBGE-tEel1Ht0ULK5IUVs7G5QotKFqoLjXSCi731WYFS4k-Ww1Ofd-3ep297EF7-ebpvMi-TK_vJ7PR_NPN7eRqPupYyaoRFa1Mo9KqxV1eFTUvOM0F5IKDpC3jkvaY533Z47pldV4JQVosqr6juMMUC3aRfTj03Tj7NUofmkH5Lu0KjLTRN7TgHBNclyyh75-haxtdGnVH5TmnJCWVqHdPVGwHKZqNUwO4bfMnigSMD0Ca23sn-yNCcLPLutll3RyzTgJ_JnQq7JeUUlT631p90B6Ultv_fNLcLebzv-5vjhjByA
CitedBy_id crossref_primary_10_1002_adfm_202407958
crossref_primary_10_3389_fimmu_2022_993168
crossref_primary_10_1002_adfm_202213342
crossref_primary_10_1016_j_ijbiomac_2024_134591
crossref_primary_10_1080_10495398_2024_2442351
crossref_primary_10_3389_fbioe_2023_1111882
crossref_primary_10_1007_s11626_023_00846_3
crossref_primary_10_1016_j_matdes_2024_113356
crossref_primary_10_1002_kjm2_70041
crossref_primary_10_1007_s40883_025_00462_5
crossref_primary_10_1155_2023_3626091
crossref_primary_10_1021_acsami_5c09766
crossref_primary_10_1002_advs_202402114
crossref_primary_10_1186_s12967_024_05492_1
crossref_primary_10_1016_j_ijbiomac_2023_126854
crossref_primary_10_1016_j_ijbiomac_2024_138384
crossref_primary_10_1038_s41598_025_16621_1
crossref_primary_10_1002_adhm_202402129
crossref_primary_10_1016_j_intimp_2025_115086
crossref_primary_10_1186_s12951_025_03098_3
crossref_primary_10_1186_s12951_023_01996_y
crossref_primary_10_31083_j_jin2309171
crossref_primary_10_1016_j_eng_2024_12_027
crossref_primary_10_1016_j_heliyon_2023_e19933
crossref_primary_10_1038_s41598_024_72593_8
crossref_primary_10_3390_biomedicines13061344
crossref_primary_10_1002_adfm_202508435
crossref_primary_10_1096_fj_202502341R
crossref_primary_10_3389_fbioe_2024_1373419
crossref_primary_10_1038_s41392_025_02124_y
crossref_primary_10_1177_20417314221143059
crossref_primary_10_1186_s40824_023_00339_0
crossref_primary_10_3389_fbioe_2023_1216878
crossref_primary_10_1016_j_intimp_2025_115330
crossref_primary_10_1016_j_bbrep_2025_102063
crossref_primary_10_1002_smll_202305659
crossref_primary_10_1080_17520363_2024_2366149
crossref_primary_10_3390_gels9110907
crossref_primary_10_1002_adhm_202304300
crossref_primary_10_1186_s12951_024_03037_8
crossref_primary_10_1016_j_intimp_2022_109120
crossref_primary_10_1002_smll_202310194
crossref_primary_10_1016_j_ijbiomac_2024_131520
crossref_primary_10_1016_j_jconrel_2025_01_007
crossref_primary_10_1007_s12035_025_04793_w
crossref_primary_10_1093_procel_pwad003
crossref_primary_10_3390_pharmaceutics15051334
crossref_primary_10_1002_adma_202413957
crossref_primary_10_1002_smll_202304318
crossref_primary_10_1002_adfm_202307711
crossref_primary_10_1063_5_0275183
crossref_primary_10_1111_cns_14550
crossref_primary_10_1111_cns_70163
crossref_primary_10_1016_j_ijbiomac_2025_146115
Cites_doi 10.1001/jama.2015.6250
10.1016/j.biomaterials.2005.11.015
10.1016/j.biomaterials.2020.119978
10.1016/j.expneurol.2013.01.026
10.1016/j.biomaterials.2018.08.037
10.1002/glia.20215
10.1089/neu.2007.0426
10.1155/2019/6146942
10.1089/neu.2009.1177
10.1016/j.biomaterials.2018.03.044
10.1016/j.addr.2017.05.010
10.1073/pnas.1820276116
10.1097/00007632-200112151-00002
10.1016/S0140-6736(02)07603-1
10.1016/j.tice.2016.05.008
10.1016/j.cellimm.2020.104047
10.1186/s12974-018-1193-6
10.1089/wound.2017.0775
10.1016/j.jconrel.2009.05.025
10.1021/acsami.8b05293
10.1089/neu.2006.23.635
10.1016/j.actbio.2019.11.012
10.1111/j.1471-4159.2011.07257.x
10.1038/nrneurol.2010.73
10.1088/1741-2560/8/4/046033
10.3389/fcell.2021.570451
10.1155/2015/948040
10.1089/ten.tea.2007.0349
10.1016/j.biomaterials.2012.03.022
10.1093/brain/awy128
10.3171/spi.2001.95.2.0221
10.2478/s11658-013-0101-4
10.1016/j.biomaterials.2017.06.019
10.1007/s10571-015-0182-x
10.1177/0363546519848678
10.1007/s13311-013-0254-x
10.1088/1741-2552/aaa55c
10.1158/1078-0432.CCR-09-1015
10.1016/S0955-0674(00)00199-X
10.1097/PRS.0b013e31829fe1b0
10.3389/fimmu.2020.02135
10.1016/j.pneurobio.2010.11.002
10.1002/adma.201501558
10.1016/S1474-4422(18)30415-0
10.1038/srep34842
10.1172/jci.insight.131355
10.1039/C7BM00485K
10.1021/cn200030w
10.4049/jimmunol.180.6.4235
10.1016/j.pneurobio.2015.09.003
10.1152/physrev.00017.2017
10.1016/j.brainresbull.2019.03.005
10.1186/s13287-016-0356-6
10.1186/s12974-020-1726-7
10.1016/j.brainres.2014.12.045
10.1016/j.pharmthera.2013.01.004
10.1038/nature04478
10.1089/ten.teb.2011.0488
10.1016/j.biopha.2017.04.126
10.1016/j.jconrel.2015.08.060
10.1111/cns.13187
10.3390/cells9092113
10.1016/S0079-6123(06)61027-3
ContentType Journal Article
Copyright 2022 Wiley‐VCH GmbH
2022 Wiley-VCH GmbH.
Copyright_xml – notice: 2022 Wiley‐VCH GmbH
– notice: 2022 Wiley-VCH GmbH.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7SR
7U5
8BQ
8FD
JG9
L7M
7X8
DOI 10.1002/smll.202107838
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Engineered Materials Abstracts
Solid State and Superconductivity Abstracts
METADEX
Technology Research Database
Materials Research Database
Advanced Technologies Database with Aerospace
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Materials Research Database
Engineered Materials Abstracts
Solid State and Superconductivity Abstracts
Technology Research Database
Advanced Technologies Database with Aerospace
METADEX
MEDLINE - Academic
DatabaseTitleList Materials Research Database
CrossRef
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1613-6829
EndPage n/a
ExternalDocumentID 35333441
10_1002_smll_202107838
SMLL202107838
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  funderid: 82072488; 82102620
– fundername: Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research
  funderid: 2019CXJQ01
– fundername: Shanghai Sailing Program
  funderid: 20YF1429900; 20YF1438100
GroupedDBID ---
05W
0R~
123
1L6
1OC
33P
3SF
3WU
4.4
50Y
52U
53G
5VS
66C
8-0
8-1
8UM
A00
AAESR
AAEVG
AAHHS
AAHQN
AAIHA
AAMNL
AANLZ
AAONW
AAXRX
AAYCA
AAZKR
ABCUV
ABIJN
ABJNI
ABLJU
ABRTZ
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACIWK
ACPOU
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZVAB
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BOGZA
BRXPI
CS3
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EMOBN
F5P
G-S
GNP
HBH
HGLYW
HHY
HHZ
HZ~
IX1
KQQ
LATKE
LAW
LEEKS
LITHE
LOXES
LUTES
LYRES
MEWTI
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
MY~
O66
O9-
OIG
P2P
P2W
P4E
QRW
R.K
RIWAO
RNS
ROL
RWI
RX1
RYL
SUPJJ
SV3
V2E
W99
WBKPD
WFSAM
WIH
WIK
WJL
WOHZO
WXSBR
WYISQ
WYJ
XV2
Y6R
ZZTAW
~S-
31~
AAMMB
AANHP
AASGY
AAYXX
ACBWZ
ACRPL
ACYXJ
ADNMO
AEFGJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
ASPBG
AVWKF
AZFZN
BDRZF
CITATION
EJD
FEDTE
GODZA
HVGLF
LH4
AAYOK
CGR
CUY
CVF
ECM
EIF
NPM
7SR
7U5
8BQ
8FD
JG9
L7M
7X8
ID FETCH-LOGICAL-c3738-2dbe24728b0c586946425da5d4ae2b34e2f045f7f09b3958dd1b0d8fc20c020d3
IEDL.DBID DRFUL
ISICitedReferencesCount 68
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000772904400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1613-6810
1613-6829
IngestDate Fri Sep 05 12:31:29 EDT 2025
Fri Jul 25 12:21:13 EDT 2025
Wed Feb 19 02:25:54 EST 2025
Sat Nov 29 04:10:40 EST 2025
Tue Nov 18 22:00:49 EST 2025
Wed Jan 22 16:26:11 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 17
Keywords STAT6
M2 polarization
spinal cord injuries
fat extract
Language English
License 2022 Wiley-VCH GmbH.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3738-2dbe24728b0c586946425da5d4ae2b34e2f045f7f09b3958dd1b0d8fc20c020d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5850-025X
PMID 35333441
PQID 2655421100
PQPubID 1046358
PageCount 14
ParticipantIDs proquest_miscellaneous_2644010973
proquest_journals_2655421100
pubmed_primary_35333441
crossref_primary_10_1002_smll_202107838
crossref_citationtrail_10_1002_smll_202107838
wiley_primary_10_1002_smll_202107838_SMLL202107838
PublicationCentury 2000
PublicationDate 2022-04-01
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Weinheim
PublicationTitle Small (Weinheim an der Bergstrasse, Germany)
PublicationTitleAlternate Small
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2015; 35
2017; 5
2019; 2019
2010; 16
2017; 2
2011; 117
2018; 168
2002; 359
2020; 17
2016; 144
2019; 18
2012; 18
2020; 11
2020; 245
2018; 7
2013; 18
2018; 9
2006; 23
2006; 27
2020; 9
2008; 25
2019; 116
2015; 219
2011; 28
2017; 122
2001; 13
2016; 48
2001; 95
2010; 6
2009; 15
2014; 11
2021; 9
2018; 141
2019; 4
2011; 2
2018; 183
2007; 161
2015; 1619
2019; 148
2005; 438
2020; 349
2001; 26
2020; 101
2012; 33
2011; 8
2008; 180
2016; 6
2016; 7
2017; 91
2015; 27
2015; 313
2011; 93
2013; 138
2019; 47
2015; 2015
2005; 52
2020; 26
2017; 140
2014; 260
2009; 140
2013; 132
2020; 21
2018; 98
2018; 10
2018; 15
e_1_2_9_31_1
e_1_2_9_52_1
e_1_2_9_50_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_56_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_54_1
Rochette L. (e_1_2_9_17_1) 2020; 21
Yu Z. (e_1_2_9_14_1) 2018; 9
e_1_2_9_39_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_58_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_20_1
e_1_2_9_62_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_24_1
e_1_2_9_43_1
Liu T. (e_1_2_9_53_1) 2017; 2
e_1_2_9_66_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_4_1
e_1_2_9_60_1
e_1_2_9_2_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_30_1
e_1_2_9_51_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_19_1
Yamazaki K. (e_1_2_9_7_1) 2020; 21
e_1_2_9_42_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_61_1
e_1_2_9_21_1
e_1_2_9_46_1
e_1_2_9_67_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_65_1
e_1_2_9_5_1
e_1_2_9_3_1
e_1_2_9_1_1
e_1_2_9_9_1
e_1_2_9_25_1
e_1_2_9_27_1
e_1_2_9_48_1
e_1_2_9_29_1
References_xml – volume: 25
  start-page: 350
  year: 2008
  publication-title: J Neurotrauma
– volume: 148
  start-page: 46
  year: 2019
  publication-title: Brain Res. Bull.
– volume: 13
  start-page: 211
  year: 2001
  publication-title: Curr. Opin. Cell Biol.
– volume: 18
  start-page: 56
  year: 2019
  publication-title: Lancet Neurol.
– volume: 15
  start-page: 595
  year: 2009
  publication-title: Tissue Eng Part A
– volume: 219
  start-page: 141
  year: 2015
  publication-title: J. Controlled Release
– volume: 2019
  year: 2019
  publication-title: Oxid. Med. Cell. Longev
– volume: 15
  year: 2018
  publication-title: J. Neural Eng.
– volume: 116
  year: 2019
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 140
  start-page: 218
  year: 2009
  publication-title: J. Controlled Release
– volume: 7
  start-page: 299
  year: 2018
  publication-title: Adv. Wound Care (New Rochelle)
– volume: 93
  start-page: 204
  year: 2011
  publication-title: Prog. Neurobiol.
– volume: 140
  start-page: 103
  year: 2017
  publication-title: Biomater.
– volume: 28
  start-page: 1611
  year: 2011
  publication-title: J. Neurotrauma
– volume: 132
  start-page: 1017
  year: 2013
  publication-title: Plast. Reconstr. Surg.
– volume: 260
  start-page: 44
  year: 2014
  publication-title: Exp Neurol
– volume: 9
  year: 2018
  publication-title: Stem Cell Res. Ther.
– volume: 98
  start-page: 881
  year: 2018
  publication-title: Physiol. Rev.
– volume: 23
  start-page: 635
  year: 2006
  publication-title: J Neurotrauma
– volume: 11
  start-page: 636
  year: 2014
  publication-title: Neurotherapeutics
– volume: 17
  start-page: 47
  year: 2020
  publication-title: J. Neuroinflammation
– volume: 122
  start-page: 74
  year: 2017
  publication-title: Adv. Drug Deliv. Rev.
– volume: 5
  start-page: 2480
  year: 2017
  publication-title: Biomater. Sci.
– volume: 9
  year: 2021
  publication-title: Front. Cell Dev. Biol.
– volume: 26
  start-page: 189
  year: 2020
  publication-title: CNS Neurosci. Ther.
– volume: 27
  start-page: 3717
  year: 2015
  publication-title: Adv. Mater.
– volume: 138
  start-page: 155
  year: 2013
  publication-title: Pharmacol. Ther.
– volume: 21
  year: 2020
  publication-title: Int. J. Mol. Sci.
– volume: 161
  start-page: 385
  year: 2007
  publication-title: Prog. Brain Res.
– volume: 144
  start-page: 188
  year: 2016
  publication-title: Prog. Neurobiol.
– volume: 35
  start-page: 881
  year: 2015
  publication-title: Cell. Mol. Neurobiol.
– volume: 27
  start-page: 2370
  year: 2006
  publication-title: Biomater.
– volume: 101
  start-page: 357
  year: 2020
  publication-title: Acta. Biomater.
– volume: 349
  year: 2020
  publication-title: Cell. Immunol.
– volume: 11
  start-page: 2135
  year: 2020
  publication-title: Front. Immunol.
– volume: 117
  start-page: 892
  year: 2011
  publication-title: J. Neurochem.
– volume: 359
  start-page: 417
  year: 2002
  publication-title: Lancet
– volume: 313
  start-page: 2236
  year: 2015
  publication-title: JAMA, J. Am. Med. Assoc.
– volume: 18
  start-page: 479
  year: 2013
  publication-title: Cell. Mol. Biol. Lett.
– volume: 8
  year: 2011
  publication-title: J. Neural Eng.
– volume: 48
  start-page: 328
  year: 2016
  publication-title: Tissue Cell
– volume: 4
  year: 2019
  publication-title: JCI Insight
– volume: 7
  start-page: 102
  year: 2016
  publication-title: Stem Cell Res. Ther.
– volume: 180
  start-page: 4235
  year: 2008
  publication-title: J. Immunol.
– volume: 141
  start-page: 1946
  year: 2018
  publication-title: Brain
– volume: 2015
  year: 2015
  publication-title: Stem Cells Int.
– volume: 168
  start-page: 24
  year: 2018
  publication-title: Biomaterials
– volume: 2
  year: 2017
  publication-title: Signal Transduct. Target Ther.
– volume: 26
  start-page: S2
  year: 2001
  publication-title: Spine (Phila Pa 1976)
– volume: 245
  year: 2020
  publication-title: Biomater.
– volume: 91
  start-page: 693
  year: 2017
  publication-title: Biomed. Pharmacother.
– volume: 438
  start-page: 932
  year: 2005
  publication-title: Nature
– volume: 95
  start-page: 221
  year: 2001
  publication-title: J. Neurosurg.
– volume: 15
  start-page: 150
  year: 2018
  publication-title: J. Neuroinflammation
– volume: 2
  start-page: 336
  year: 2011
  publication-title: ACS Chem. Neurosci.
– volume: 183
  start-page: 114
  year: 2018
  publication-title: Biomater.
– volume: 18
  start-page: 101
  year: 2012
  publication-title: Tissue Eng. Part B Rev.
– volume: 9
  start-page: 2113
  year: 2020
  publication-title: Cells
– volume: 47
  start-page: 1722
  year: 2019
  publication-title: Am. J. Sports Med.
– volume: 1619
  start-page: 1
  year: 2015
  publication-title: Brain Res.
– volume: 52
  start-page: 16
  year: 2005
  publication-title: Glia
– volume: 16
  start-page: 784
  year: 2010
  publication-title: Clin. Cancer Res.
– volume: 6
  year: 2016
  publication-title: Sci. Rep.
– volume: 33
  start-page: 4555
  year: 2012
  publication-title: Biomater.
– volume: 10
  year: 2018
  publication-title: ACS Appl. Mater. Interfaces
– volume: 6
  start-page: 363
  year: 2010
  publication-title: Nat. Rev. Neurol.
– ident: e_1_2_9_1_1
  doi: 10.1001/jama.2015.6250
– ident: e_1_2_9_21_1
  doi: 10.1016/j.biomaterials.2005.11.015
– volume: 9
  year: 2018
  ident: e_1_2_9_14_1
  publication-title: Stem Cell Res. Ther.
– ident: e_1_2_9_67_1
  doi: 10.1016/j.biomaterials.2020.119978
– ident: e_1_2_9_45_1
  doi: 10.1016/j.expneurol.2013.01.026
– volume: 2
  year: 2017
  ident: e_1_2_9_53_1
  publication-title: Signal Transduct. Target Ther.
– ident: e_1_2_9_32_1
  doi: 10.1016/j.biomaterials.2018.08.037
– ident: e_1_2_9_43_1
  doi: 10.1002/glia.20215
– ident: e_1_2_9_62_1
  doi: 10.1089/neu.2007.0426
– ident: e_1_2_9_29_1
  doi: 10.1155/2019/6146942
– ident: e_1_2_9_26_1
  doi: 10.1089/neu.2009.1177
– ident: e_1_2_9_60_1
  doi: 10.1016/j.biomaterials.2018.03.044
– ident: e_1_2_9_40_1
  doi: 10.1016/j.addr.2017.05.010
– ident: e_1_2_9_41_1
  doi: 10.1073/pnas.1820276116
– ident: e_1_2_9_2_1
  doi: 10.1097/00007632-200112151-00002
– ident: e_1_2_9_3_1
  doi: 10.1016/S0140-6736(02)07603-1
– ident: e_1_2_9_5_1
  doi: 10.1016/j.tice.2016.05.008
– ident: e_1_2_9_25_1
  doi: 10.1016/j.cellimm.2020.104047
– ident: e_1_2_9_56_1
  doi: 10.1186/s12974-018-1193-6
– ident: e_1_2_9_28_1
  doi: 10.1089/wound.2017.0775
– ident: e_1_2_9_35_1
  doi: 10.1016/j.jconrel.2009.05.025
– ident: e_1_2_9_63_1
  doi: 10.1021/acsami.8b05293
– ident: e_1_2_9_65_1
  doi: 10.1089/neu.2006.23.635
– ident: e_1_2_9_49_1
  doi: 10.1016/j.actbio.2019.11.012
– ident: e_1_2_9_59_1
  doi: 10.1111/j.1471-4159.2011.07257.x
– ident: e_1_2_9_6_1
  doi: 10.1038/nrneurol.2010.73
– volume: 21
  year: 2020
  ident: e_1_2_9_17_1
  publication-title: Int. J. Mol. Sci.
– ident: e_1_2_9_44_1
  doi: 10.1088/1741-2560/8/4/046033
– ident: e_1_2_9_55_1
  doi: 10.3389/fcell.2021.570451
– ident: e_1_2_9_27_1
  doi: 10.1155/2015/948040
– ident: e_1_2_9_34_1
  doi: 10.1089/ten.tea.2007.0349
– ident: e_1_2_9_23_1
  doi: 10.1016/j.biomaterials.2012.03.022
– ident: e_1_2_9_9_1
  doi: 10.1093/brain/awy128
– ident: e_1_2_9_38_1
  doi: 10.3171/spi.2001.95.2.0221
– ident: e_1_2_9_15_1
  doi: 10.2478/s11658-013-0101-4
– ident: e_1_2_9_12_1
  doi: 10.1016/j.biomaterials.2017.06.019
– ident: e_1_2_9_47_1
  doi: 10.1007/s10571-015-0182-x
– ident: e_1_2_9_16_1
  doi: 10.1177/0363546519848678
– ident: e_1_2_9_57_1
  doi: 10.1007/s13311-013-0254-x
– ident: e_1_2_9_64_1
  doi: 10.1088/1741-2552/aaa55c
– ident: e_1_2_9_52_1
  doi: 10.1158/1078-0432.CCR-09-1015
– ident: e_1_2_9_51_1
  doi: 10.1016/S0955-0674(00)00199-X
– ident: e_1_2_9_61_1
  doi: 10.1097/PRS.0b013e31829fe1b0
– ident: e_1_2_9_48_1
  doi: 10.3389/fimmu.2020.02135
– ident: e_1_2_9_18_1
  doi: 10.1016/j.pneurobio.2010.11.002
– ident: e_1_2_9_36_1
  doi: 10.1002/adma.201501558
– ident: e_1_2_9_4_1
  doi: 10.1016/S1474-4422(18)30415-0
– ident: e_1_2_9_11_1
  doi: 10.1038/srep34842
– ident: e_1_2_9_24_1
  doi: 10.1172/jci.insight.131355
– ident: e_1_2_9_66_1
  doi: 10.1039/C7BM00485K
– ident: e_1_2_9_20_1
  doi: 10.1021/cn200030w
– ident: e_1_2_9_50_1
  doi: 10.4049/jimmunol.180.6.4235
– ident: e_1_2_9_42_1
  doi: 10.1016/j.pneurobio.2015.09.003
– ident: e_1_2_9_8_1
  doi: 10.1152/physrev.00017.2017
– ident: e_1_2_9_22_1
  doi: 10.1016/j.brainresbull.2019.03.005
– ident: e_1_2_9_30_1
  doi: 10.1186/s13287-016-0356-6
– ident: e_1_2_9_54_1
  doi: 10.1186/s12974-020-1726-7
– ident: e_1_2_9_46_1
  doi: 10.1016/j.brainres.2014.12.045
– ident: e_1_2_9_58_1
  doi: 10.1016/j.pharmthera.2013.01.004
– ident: e_1_2_9_39_1
  doi: 10.1038/nature04478
– ident: e_1_2_9_13_1
  doi: 10.1089/ten.teb.2011.0488
– ident: e_1_2_9_10_1
  doi: 10.1016/j.biopha.2017.04.126
– ident: e_1_2_9_19_1
  doi: 10.1016/j.jconrel.2015.08.060
– ident: e_1_2_9_31_1
  doi: 10.1111/cns.13187
– volume: 21
  year: 2020
  ident: e_1_2_9_7_1
  publication-title: Int. J. Mol. Sci.
– ident: e_1_2_9_33_1
  doi: 10.3390/cells9092113
– ident: e_1_2_9_37_1
  doi: 10.1016/S0079-6123(06)61027-3
SSID ssj0031247
Score 2.5956259
Snippet Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e2107838
SubjectTerms Animals
Biocompatibility
Biological activity
Biomedical materials
Cell Extracts
Cytokines
Cytokines - metabolism
fat extract
Genotype & phenotype
Humans
Hyaluronic acid
Hyaluronic Acid - pharmacology
Hydrogels
Inflammation - drug therapy
Inflammation - metabolism
Injury prevention
M2 polarization
Macrophages
Mice
Microglia
Nanotechnology
Polarization
Spinal cord
Spinal cord injuries
Spinal Cord Injuries - drug therapy
STAT6
Title Cell‐Free Extracts from Human Fat Tissue with a Hyaluronan‐Based Hydrogel Attenuate Inflammation in a Spinal Cord Injury Model through M2 Microglia/Microphage Polarization
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsmll.202107838
https://www.ncbi.nlm.nih.gov/pubmed/35333441
https://www.proquest.com/docview/2655421100
https://www.proquest.com/docview/2644010973
Volume 18
WOSCitedRecordID wos000772904400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1613-6829
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0031247
  issn: 1613-6810
  databaseCode: DRFUL
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELbolgM98E8JlMpISJyide38OEdYGhVpt6poK-0tsmO7LArZVZJFcOMReBPeiSdhJsmGrhBCglsS24mlmfF8Y2e-IeSFi1nOwlD7kVbMD-xR4idxHvqRY8zKKBGWubbYRHx6Kufz5OxaFn_HDzFsuKFltOs1GrjS9fgXaWj9scCjAwhZYinkDtnloLzBiOy-eZdeTjersQD_1RZYAbflI_fWhriR8fH2G7Yd029ocxu8tt4nvfP_875LbvfIk77qVOUeuWHL-2TvGh_hA_J9Yovix9dvaWUtPf7cYAZVTTEDhbab_TRVDb1oRUVxA5cqevJFFesK4HwJ416DSzTwyFTLKwufagCQrwHM0relA83rsiTpooRx5yssx0UnEPtC6weQLMWybAXtCwfRGacz_FnwqliocXu1eg9rHz3DWLxPHn1ILtPji8mJ31d08HNkUPK50RbkwaVmeQiaEED0ExoVmkBZrkVguQOI6WLHEi2SUBpzpJmRLuegUZwZ8YiMymVpHxOa61BHEbMQryWBDBwenzIZa-WEVEYlHvE34szynu4cq24UWUfUzDMURDYIwiMvh_6rjujjjz0PNtqR9QZfZzwCXIbBNPPI86EZTBXPX1Rpl2vsEwR4EhkLj-x3WjV8SgDsFgBNPcJb5fnLHLLz2XQ63D35l0FPyS2OqRztX0gHZNRUa_uM3Mw_NYu6OiQ78Vwe9sb0E_HbIfk
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtMwELagiwQc-F0gsICRkDhF9dr5cY5QNuqKtFqxXWlvkR3bS1FIq7RFcOMReBPeiSdhJkkDFUJIiFt-7DjSzHi-sT3fEPLcxaxgYaj9SCvmB_Yw8ZO4CP3IMWZllAjLXFNsIp5O5fl5ctKdJsRcmJYfol9wQ8to5ms0cFyQHv5kDV19KHHvAGKWWAp5mewFoEvhgOy9fpueZdvpWIADayqsgN_ykXxry9zI-HD3C7ue6Te4uYteG_eT3vwPP36L3OiwJ33ZKsttcslWd8j1XxgJ75JvI1uW3798TWtr6dGnNeZQrSjmoNBmuZ-mak1njbAoLuFSRcefVbmpAdBX0O8VOEUDj0y9uLAw1Bog-QbgLD2uHOhemydJ5xX0O11iQS46gugX3r4H2VIszFbSrnQQnXA6weOCF-VcDZur5TuY_egJRuNd-ug-OUuPZqOx39V08AvkUPK50RYEwqVmRQi6EED8ExoVmkBZrkVguQOQ6WLHEi2SUBpzqJmRruCgU5wZcY8MqkVlHxBa6FBHEbMQsSWBDBxuoDIZa-WEVEYlHvG38syLjvAc626UeUvVzHMURN4LwiMv-vbLlurjjy0PtuqRdya_ynkEyAzDaeaRZ_1rMFbcgVGVXWywTRDgXmQsPHK_Vat-KAHAWwA49QhvtOcv_5CfTrKsv3v4L52ekqvj2STLs-Ppm0fkGsfEjuZM0gEZrOuNfUyuFB_X81X9pLOpH21HJQE
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagRQgO_BcCBYyExCla186Pc4Rto1bsrla0lXqL7NguW4XsKptFcOMReJO-U5-EmSQbWCGEhLjlx44jzYznG9vzDSGvXcxyFobaj7RifmD3Ej-J89CPHGNWRomwzDXFJuLJRJ6dJdPuNCHmwrT8EP2CG1pGM1-jgduFcYOfrKHLTwXuHUDMEkshr5PtIEwisM3t_Q_p6Wg9HQtwYE2FFfBbPpJvrZkbGR9sfmHTM_0GNzfRa-N-0rv_4cfvkTsd9qRvW2W5T67Z8gG5_Qsj4UNyObRFcfXte1pZSw--1JhDtaSYg0Kb5X6aqpqeNMKiuIRLFT38qopVBYC-hH7vwCkaeGSq-bmFoWqA5CuAs_SodKB7bZ4knZXQ73iBBbnoEKJfeHsBsqVYmK2gXekgOuZ0jMcFz4uZGjRXi48w-9EpRuNd-ugjcpoenAwP_a6mg58jh5LPjbYgEC41y0PQhQDin9Co0ATKci0Cyx2ATBc7lmiRhNKYPc2MdDkHneLMiB2yVc5L-4TQXIc6ipiFiC0JZOBwA5XJWCsnpDIq8Yi_lmeWd4TnWHejyFqqZp6hILJeEB5507dftFQff2y5u1aPrDP5ZcYjQGYYTjOPvOpfg7HiDowq7XyFbYIA9yJj4ZHHrVr1QwkA3gLAqUd4oz1_-YfseDwa9XdP_6XTS3Jzup9mo6PJ-2fkFse8juZI0i7ZqquVfU5u5J_r2bJ60ZnUD8JOJHw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cell%E2%80%90Free+Extracts+from+Human+Fat+Tissue+with+a+Hyaluronan%E2%80%90Based+Hydrogel+Attenuate+Inflammation+in+a+Spinal+Cord+Injury+Model+through+M2+Microglia%2FMicrophage+Polarization&rft.jtitle=Small+%28Weinheim+an+der+Bergstrasse%2C+Germany%29&rft.au=Xu%2C+Guang%E2%80%90Yu&rft.au=Xu%2C+Shun&rft.au=Zhang%2C+Yu%E2%80%90Xuan&rft.au=Yu%2C+Zi%E2%80%90You&rft.date=2022-04-01&rft.issn=1613-6810&rft.eissn=1613-6829&rft.volume=18&rft.issue=17&rft_id=info:doi/10.1002%2Fsmll.202107838&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_smll_202107838
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1613-6810&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1613-6810&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1613-6810&client=summon